Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Pancreatic cancer has a complex tumor microenvironment which engages in extensive crosstalk between cancer cells, cancer-associated fibroblasts, and immune cells. Many of these interactions contribute to tumor resistance to anti-cancer therapies. Here, new therapeutic strategies designed to modulate...
Main Authors: | Nebojsa Skorupan, Mayrel Palestino Dominguez, Samuel L. Ricci, Christine Alewine |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/17/4209 |
Similar Items
-
Metastatic Transition of Pancreatic Ductal Cell Adenocarcinoma Is Accompanied by the Emergence of Pro-Invasive Cancer-Associated Fibroblasts
by: Shaofei Liu, et al.
Published: (2022-04-01) -
Uncovering Tumor‐Promoting Roles of Activin A in Pancreatic Ductal Adenocarcinoma
by: Seok‐Yeong Yu, et al.
Published: (2023-06-01) -
The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma
by: Alexander A. Lekan, et al.
Published: (2024-01-01) -
Targeting and Reprograming Cancer-Associated Fibroblasts and the Tumor Microenvironment in Pancreatic Cancer
by: Yoshiaki Sunami, et al.
Published: (2021-02-01) -
Targeted drug delivery systems for pancreatic ductal adenocarcinoma: overcoming tumor microenvironment challenges with CAF-specific nanoparticles
by: Xinming Su, et al.
Published: (2023-12-01)